Company Overview
Snapshot
Founded in January 2008 by Boaz Behar, Perseus Biomed operates with 1–10 employees. The company is currently in a Pre-Funding stage, developing a one-time treatment modality for hypertension and other diseases.
Business overview
Perseus Biomed is a medical device startup focused on developing a one-time treatment modality for hypertension and other diseases. The company's patent-pending technology is designed to perform accurate, effective, and safe tissue ablation through a 30-minute procedure. Perseus Biomed operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Treatment & Therapeutics categories, with a focus on healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- Who founded Perseus Biomed?
- Perseus Biomed was founded by Boaz Behar, who also serves as the CEO.
- When was Perseus Biomed founded?
- Perseus Biomed was founded in January 2008.
- What is Perseus Biomed's primary focus?
- Perseus Biomed is developing a one-time treatment modality for hypertension and other diseases using a patent-pending tissue ablation technology.
- What is the current product stage of Perseus Biomed's technology?
- Perseus Biomed's product is currently in the Clinical Trial stage, having conducted multiple studies to prove its safety and efficacy.
- In which sector does Perseus Biomed primarily operate?
- Perseus Biomed operates primarily in the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics.